1
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Breast Neoplasms
13132
Neoplasms
10477
Carcinoma, Non-Small-Cell Lung
6870
Prostatic Neoplasms
6268
Colorectal Neoplasms
5945
Lung Neoplasms
5102
Multiple Myeloma
3576
Pancreatic Neoplasms
3561
Leukemia, Myeloid, Acute
3510
Neoplasm Metastasis
3507
Carcinoma, Hepatocellular
3271
Ovarian Neoplasms
3168
Melanoma
3139
Stomach Neoplasms
3056
Lymphoma
2982
Head and Neck Neoplasms
2603
Recurrence
2556
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2499
Leukemia
2362
Colonic Neoplasms
2327
Brain Neoplasms
2310
Lymphoma, Non-Hodgkin
2268
Rectal Neoplasms
2191
Uterine Cervical Neoplasms
2191
Glioblastoma
2014
Leukemia, Lymphocytic, Chronic, B-Cell
1992
Carcinoma, Renal Cell
1913
Squamous Cell Carcinoma of Head and Neck
1880
Lymphoma, Follicular
1847
Esophageal Neoplasms
1800
Interventions
salicylhydroxamic acid
1
Triamcinolone Acetonide
1
Ranibizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Choroid Diseases
×
Clear all
NCT00811200
2009-07-02
TORR
Leiden University Medical Center
Phase 2/3
Unknown
220 enrolled